- Download: PDF | Citation | XML
- Print article
- EzReprint New & improved!
Published in the May 2007 Issue of PLoS Medicine
Share this Article info
Open Access
Correction
Correction: A Challenge for the Development of Malaria Vaccines: Polymorphic Target Antigens
- To add a note, highlight some text. Hide notes
- Make a general comment
Citation: Sutherland C (2007) Correction: A Challenge for the Development of Malaria Vaccines: Polymorphic Target Antigens. PLoS Med 4(5): e175. doi:10.1371/journal.pmed.0040175
Published: May 29, 2007
This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
In PLoS Medicine, volume 4, issue 3, doi: 10.1371/journal.pmed.0040116:
In this Perspective, the surname of the lead author of the related research article [Takala SL, Coulibaly D, Thera MA, Dicko A, Smith DL, et al. (2007) Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali. PLoS Med 4: e93. doi:10.1371/journal.pmed.0040093] was misspelled as Takkala in all but the first use. The correct spelling is Takala.
In addition, the amino acid residues cited in the following sentence should be “1691, 1701, or 1716,” rather than “1691, 1700, or 1716”:
“For a given surveillance interval in which two infections occurred in the same patient, infection with a haplotype differing in amino acid sequence at residue 1691, 1700, or 1716 was significantly associated with risk of clinical malaria in the latter episode.”
Add a note to this text.
Post Your Note (For Public Viewing)